Literature DB >> 26095851

Cyclophilin A regulates JNK/p38-MAPK signaling through its physical interaction with ASK1.

Hunsung Kim1, Yoojung Oh1, Kiyoon Kim1, Suyun Jeong1, Suk Chon2, Daehong Kim3, Min Hyung Jung4, Youngmi Kim Pak5, Joohun Ha1, Insug Kang1, Wonchae Choe6.   

Abstract

Cyclophilin A (CypA), a member of the immunophilin family, is predominantly localized in the cytoplasm. The peptidylprolyl isomerase (PPIase) activity of CypA has been demonstrated to be involved in diverse cellular processes, including intracellular protein trafficking, mitochondrial function, pre-mRNA processing, and maintenance of multiprotein complex stability. In this study, we have demonstrated that CypA regulates apoptosis signaling-regulating kinase 1 (ASK1) through its direct binding. ASK1 is a member of MAPK kinase kinase (MAP3K) family, and selectively activates both JNK and p38 MAPK pathways. Here, we also report that CypA negatively regulates phosphorylation of ASK1 at Ser966, and that CypA reduces ASK1 and its downstream kinases of the JNK and p38 signaling. ASK1 is known to induce caspase-3 activation and apoptosis, and CypA inhibited ASK1-mediated apoptosis by decrease in caspase-3 activity under cellular stress conditions. Overall, we conclude that CypA negatively regulates ASK1 functions by its physical interaction with ASK1.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Apoptosis signal-regulating kinase 1(ASK1); Cyclophilin A (CypA); Mitogen-activated protein kinase (MAPK); Oxidative-stress

Mesh:

Substances:

Year:  2015        PMID: 26095851     DOI: 10.1016/j.bbrc.2015.06.078

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Cyclophilin a represses reactive oxygen species generation and death of hypoxic non-small-cell lung cancer cells by degrading thioredoxin-interacting protein.

Authors:  Yang Li; Lan Yang
Journal:  Cell Cycle       Date:  2022-05-30       Impact factor: 5.173

2.  Theabrownin Induces Apoptosis and Tumor Inhibition of Hepatocellular Carcinoma Huh7 Cells Through ASK1-JNK-c-Jun Pathway.

Authors:  Jiaan Xu; Bo Yan; Lei Zhang; Li Zhou; Jin Zhang; Wenhua Yu; Xiaoqiao Dong; Li Yao; Letian Shan
Journal:  Onco Targets Ther       Date:  2020-09-09       Impact factor: 4.147

3.  β-Ecdysterone protects SH-SY5Y cells against β-amyloid-induced apoptosis via c-Jun N-terminal kinase- and Akt-associated complementary pathways.

Authors:  Xiaojie Zhang; Miaoxian Dong; Tianjiao Xu; Chengu Niu
Journal:  Lab Invest       Date:  2018-01-12       Impact factor: 5.662

4.  Ugonin U stimulates NLRP3 inflammasome activation and enhances inflammasome-mediated pathogen clearance.

Authors:  Chun-Yu Chen; Chuan-Hui Yang; Yung-Fong Tsai; Chih-Chuang Liaw; Wen-Yi Chang; Tsong-Long Hwang
Journal:  Redox Biol       Date:  2016-12-18       Impact factor: 11.799

5.  Astroglial DJ-1 over-expression up-regulates proteins involved in redox regulation and is neuroprotective in vivo.

Authors:  Ann Kristin Frøyset; Amanda J Edson; Naouel Gharbi; Essa A Khan; Daniel Dondorp; Qing Bai; Ettore Tiraboschi; Maximiliano L Suster; Joanne B Connolly; Edward A Burton; Kari E Fladmark
Journal:  Redox Biol       Date:  2018-02-17       Impact factor: 11.799

6.  Inhibition of cyclophilin A suppresses H2O2-enhanced replication of HCMV through the p38 MAPK signaling pathway.

Authors:  Jun Xiao; Xin Song; Jiang Deng; Liping Lv; Ping Ma; Bo Gao; Xipeng Zhou; Yanyu Zhang; Jinbo Xu
Journal:  FEBS Open Bio       Date:  2016-08-15       Impact factor: 2.693

7.  Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson's Disease.

Authors:  Fábio G Teixeira; Helena Vilaça-Faria; Ana V Domingues; Jonas Campos; António J Salgado
Journal:  Cells       Date:  2020-01-28       Impact factor: 6.600

8.  Cyclophilin A promotes non-small cell lung cancer metastasis via p38 MAPK.

Authors:  Yinan Guo; Mei Jiang; Xiaoting Zhao; Meng Gu; Ziyu Wang; Shaofa Xu; Wentao Yue
Journal:  Thorac Cancer       Date:  2017-11-07       Impact factor: 3.500

Review 9.  ASK1 inhibition: a therapeutic strategy with multi-system benefits.

Authors:  Jacqueline M Ogier; Bryony A Nayagam; Paul J Lockhart
Journal:  J Mol Med (Berl)       Date:  2020-02-14       Impact factor: 4.599

10.  Prdx1 Interacts with ASK1 upon Exposure to H2O2 and Independently of a Scaffolding Protein.

Authors:  Trung Nghia Vo; Julia Malo Pueyo; Khadija Wahni; Daria Ezeriņa; Jesalyn Bolduc; Joris Messens
Journal:  Antioxidants (Basel)       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.